Lexicon Pharmaceuticals financial statements

렉시콘 파머슈티컬스NASDAQ:LXRX · Nasdaq · Healthcare · sector #17
$1.75+0.57%
2026-10-06 close

Lexicon Pharmaceuticals's published financial data is dated 2026-10-04. 2024 revenue was $31M. 2024 operating profit was −$197M.

Reported results

Lexicon Pharmaceuticals notifications

Quantus Signal · live data · not investment advice · Privacy Policy